Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16,506 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High red blood cell distribution width attenuates the effectiveness of Immune checkpoint inhibitor therapy: An exploratory study using a clinical data warehouse.
Matsumoto H, Fukushima T, Kobayashi N, Higashino Y, Muraoka S, Ohtsu Y, Hirata M, Somekawa K, Kaneko A, Nagasawa R, Kubo S, Tanaka K, Murohashi K, Fujii H, Watanabe K, Horita N, Hara Y, Kaneko T. Matsumoto H, et al. Among authors: watanabe k. PLoS One. 2024 Aug 1;19(8):e0299760. doi: 10.1371/journal.pone.0299760. eCollection 2024. PLoS One. 2024. PMID: 39088539 Free PMC article.
T-cell response to phytohemagglutinin in the interferon-γ release assay as a potential biomarker for the response to immune checkpoint inhibitors in patients with non-small cell lung cancer.
Kamimaki C, Kobayashi N, Hirata M, Somekawa K, Fukuda N, Kubo S, Katakura S, Teranishi S, Watanabe K, Horita N, Hara Y, Yamamoto M, Kudo M, Piao H, Kaneko T. Kamimaki C, et al. Among authors: watanabe k. Thorac Cancer. 2021 Jun;12(11):1726-1734. doi: 10.1111/1759-7714.13978. Epub 2021 May 4. Thorac Cancer. 2021. PMID: 33943031 Free PMC article.
Best regimens for treating chemo-naïve incurable squamous non-small cell lung cancer with a programmed death-ligand 1 tumor proportion score of 1%-49%: A network meta-analysis.
Fukuda N, Horita N, Namkoong H, Kaneko A, Somekawa K, Tagami Y, Watanabe K, Hara Y, Kobayashi N, Kaneko T. Fukuda N, et al. Among authors: watanabe k. Thorac Cancer. 2022 Jan;13(1):84-94. doi: 10.1111/1759-7714.14229. Epub 2021 Nov 17. Thorac Cancer. 2022. PMID: 34791815 Free PMC article.
Pembrolizumab monotherapy versus pembrolizumab plus chemotherapy in patients with non-small-cell lung cancer: A multicenter retrospective trial.
Matsumoto H, Kobayashi N, Somekawa K, Fukuda N, Kaneko A, Kamimaki C, Kubo S, Tanaka K, Tagami Y, Teranishi S, Watanabe K, Horita N, Hara Y, Yamamoto M, Kudo M, Koizumi H, Miura K, Miyazawa N, Kaneko T. Matsumoto H, et al. Among authors: watanabe k. Thorac Cancer. 2022 Jan;13(2):228-235. doi: 10.1111/1759-7714.14252. Epub 2021 Dec 5. Thorac Cancer. 2022. PMID: 34866339 Free PMC article.
Afatinib + bevacizumab combination therapy in EGFR-mutant NSCLC patients with osimertinib resistance: Protocol of an open-label, phase II, multicenter, single-arm trial.
Kobayashi N, Hashimoto H, Kamimaki C, Nagasawa R, Tanaka K, Kubo S, Katakura S, Chen H, Hirama N, Ushio R, Aoki A, Nakashima K, Teranishi S, Manabe S, Watanabe H, Horita N, Watanabe K, Hara Y, Yamamoto M, Kudo M, Piao H, Kaneko T. Kobayashi N, et al. Among authors: watanabe h, watanabe k. Thorac Cancer. 2020 Aug;11(8):2125-2129. doi: 10.1111/1759-7714.13503. Epub 2020 Jun 3. Thorac Cancer. 2020. PMID: 32495514 Free PMC article. Clinical Trial.
MicroRNA-200b is a potential biomarker of the expression of PD-L1 in patients with lung cancer.
Katakura S, Kobayashi N, Hashimoto H, Kamimaki C, Tanaka K, Kubo S, Nakashima K, Teranishi S, Manabe S, Watanabe K, Horita N, Hara Y, Yamamoto M, Kudo M, Piao H, Kaneko T. Katakura S, et al. Among authors: watanabe k. Thorac Cancer. 2020 Oct;11(10):2975-2982. doi: 10.1111/1759-7714.13653. Epub 2020 Sep 7. Thorac Cancer. 2020. PMID: 32893980 Free PMC article.
16,506 results
You have reached the last available page of results. Please see the User Guide for more information.